Paper - WANFANG MED ONLINE

You Position: Home > Paper

Diagnosis and treatment of gastrointestinal stromal tumors

( views:322, downloads:288 )

Author:: No author available

Journal Title:: WORLD CHINESE JOURNAL OF DIGESTOLOGY

Issue:: 1

DOI:: 10.3969/j.issn.1009-3079.2010.01.012

Key Word:: 胃肠遭间质瘤;诊断;分子靶向治疗

Abstract：胃肠道间质瘤(gastrointestinal stromal tumors,GIST)是消化系最常见的间叶组织源性肿瘤,是一种潜在恶性的肿瘤.其临床表现缺乏特异性,术前诊断上存在较大困难.近几年其发病机制已经逐渐被人们所认识,诊断及治疗水平上也有了很大的提高.原癌基因kit突变是其主要发病机制之一.以CD117为代表的免疫织化学染色在其诊断中作为一个重要的决定性因素.治疗上目前注重于综合治疗,手术完整切除仍然是其首选治疗,包括新辅助治疗及术后辅助治疗在内的分子靶向治疗的出现成为GIST治疗上的一次巨大进步,甲磺酸伊马替尼等选择性酪氨酸激酶抑制剂制剂的出现,给GIST患者的治疗带来了新的希望.

Reference

[1]吴斌,邱辉忠,肖毅,等.胃间质瘤的手术治疗[J].2005,(3).
[2]胡伟国,马君俊,陆爱国,等.腹腔镜手术治疗胃和小肠间质瘤[J].2007,(1).
[3]戴冬秋,马振海.胃间质瘤的外科治疗[J].2006,(8).
[4]廖世兵,秦叔逵.胃肠道间质瘤的现状和未来[J].2006,(8).
[5]季加孚.小肠间质瘤的诊断与治疗[J].2008,(8).
[6]顾晋,姚云峰.胃肠间质瘤新辅助与术后辅助治疗[J].2008,(4).
[7]何裕隆.胃肠间质瘤外科治疗的选择[J].2006,(1).
[8]张信华,何裕隆.十二指肠间质瘤的诊治和讨论[J].2008,(4).
[9]师英强,杜春燕.胃肠间质瘤的外科治疗问题[J].2006,(8).
[10]李金丽,王仁本,于金明.胃肠间质瘤诊治进展[J].2006,(20).
[11]Ogun G,vel-Dobosz AJ,Ruka W,etc.Presence of homozygous KIT exon 11 mutations is strongly associated with malignant clinical behavior in gastrointestinal stromal tumors.[J].2007,87(10).
[12]Sarran L,Antonescu CR,Rosenberg AE,etc.Multiple gastrointestinal stromal tumors in type I neurofibromatosis: a pathologic and molecular study.[J].2005,18(4).
[13]Reichardt P,Demetri GD,Dei Tos AP,etc.Consensus meeting for the management of gastrointestinal stromal tumors. Report of the GIST Consensus Conference of 20-21 March 2004, under the auspices of ESMO.[J].2005,16(4).
[14]Joensuu H.Risk stratification of patients diagnosed with gastrointestinal stromal tumor.[J].2008,39(10).
[15]Poston GJ,Ye YJ,Gao ZD.Diagnosis and multi-disciplinary management of hepatic metastases from gastrointestinal stromal tumour (GIST).[J].2009,35(8).
[16]Hassan I,Schleck CD,Dozois EJ,etc.Surgically managed gastrointestinal stromal tumors: a comparative and prognostic analysis.[J].2008,15(1).
[17]主编李健丁，靳宏星，武志峰.胃肠道间质瘤影像诊断[M].1900.
[18]Takahashi T,Nakajima K,Nishitani A,etc.An enhanced risk-group stratification system for more practical prognostication of clinically malignant gastrointestinal stromal tumors.[J].2007,12(5).
[19]Hornick JL,Fletcher CD.The role of KIT in the management of patients with gastrointestinal stromal tumors.[J].2007,38(5).
[20]Andtbacka RH,Ng CS,Scaife CL,etc.Surgical resection of gastrointestinal stromal tumors after treatment with imatinib.[J].2007,14(1).
[21]Ekmektzoglou KA,Zografos GC,Samelis GF.Gastrointestinal stromal tumours: clinical overview, surgery and recent advances in imatinib mesylate therapy.[J].2007,33(8).
[22]Parfitt JR,Riddell RH,Streutker CJ,etc.Gastrointestinal stromal tumors: A contemporary review.[J].2006,202(12).
[23]Halina, Cichoz-Lach,Beata, Kasztelan-Szczerbińska,Maria, S?omka.Gastrointestinal stromal tumors: epidemiology, clinical picture, diagnosis, prognosis and treatment.[J].2008,118(4).